Showing results (381-390 of 399) with videos related to
Sort By:
Pageof 40
Journal of Virology|June 20, 2008
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changesToshiyuki Miura, Mark A Brockman, Chanson J Brumme, et al.Journal of Advances in Modeling Earth Systems|July 21, 2022
The Terrestrial Biosphere Model FarmJoshua B Fisher, Munish Sikka, Gary L Block, et al.Journal of the American Heart Association|April 2, 2015
Growth hormone-releasing hormone agonists reduce myocardial infarct scar in swine with subacute ischemic cardiomyopathyLuiza L Bagno, Rosemeire M Kanashiro-Takeuchi, Viky Y Suncion, et al.Journal of Virology|July 11, 2008
Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infectionZabrina L Brumme, Chanson J Brumme, Jonathan Carlson, et al.The Journal of Experimental Medicine|September 2, 2015
NOS1-derived nitric oxide promotes NF-κB transcriptional activity through inhibition of suppressor of cytokine signaling-1Mirza Saqib Baig, Sofia V Zaichick, Mao Mao, et al.Journal of Virology|January 1, 2009
HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte [corrected] recognitionToshiyuki Miura, Mark A Brockman, Arne Schneidewind, et al.Journal of Virology|May 28, 2010
Impaired replication capacity of acute/early viruses in persons who become HIV controllersToshiyuki Miura, Zabrina L Brumme, Mark A Brockman, et al.Pediatrics|September 5, 2023
Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and SafetyJaime Restrepo, Teobaldo Herrera, Rudiwilai Samakoses, et al.The New England Journal of Medicine|December 22, 2016
Shortened Antimicrobial Treatment for Acute Otitis Media in Young ChildrenAlejandro Hoberman, Jack L Paradise, Howard E Rockette, et al.Pediatrics|July 17, 2016
Safety Profile of the 9-Valent HPV Vaccine: A Combined Analysis of 7 Phase III Clinical TrialsEdson D Moreira, Stan L Block, Daron Ferris, et al.Pageof 40